Gilgamesh Pharmaceuticals
0 followers
‌
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy.
Industries
Headquarters
Employees
Links
Org chart
Jonathan Sporn
CEO & Co-Founder
Jonathan Sporn
Collapse
Dalibor Sames
Co-founder
Andrew Kruegel
Chief Scientific Officer
Mike Cunningham
Co-founder
Jeff Witkin
Preclinical Pharmacologist & Co-Founder
Jay Gingrich
Consultant
Daniel Umbricht
Head Of Clinical Development
Robert Berman
Consultant
Eric Austin
Head of Toxicology and ADME
Grace Parker
Preclinical Projects Manager
William Leong
EVP, Head of CMC
Yoni Falkson
Chief Operating Officer
